NeuroOne Medical Technologies (NMTC) Competitors $0.71 -0.07 (-8.96%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NMTC vs. CEMI, IDXG, LNSR, TMDIF, TELA, MGRM, HSAQ, MODD, NSPR, and NVNOShould you be buying NeuroOne Medical Technologies stock or one of its competitors? The main competitors of NeuroOne Medical Technologies include Chembio Diagnostics (CEMI), Interpace Biosciences (IDXG), LENSAR (LNSR), Titan Medical (TMDIF), TELA Bio (TELA), Monogram Orthopaedics (MGRM), Health Sciences Acquisitions Co. 2 (HSAQ), Modular Medical (MODD), InspireMD (NSPR), and enVVeno Medical (NVNO). These companies are all part of the "medical" sector. NeuroOne Medical Technologies vs. Chembio Diagnostics Interpace Biosciences LENSAR Titan Medical TELA Bio Monogram Orthopaedics Health Sciences Acquisitions Co. 2 Modular Medical InspireMD enVVeno Medical Chembio Diagnostics (NASDAQ:CEMI) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, analyst recommendations, risk and dividends. Does the MarketBeat Community prefer CEMI or NMTC? Chembio Diagnostics received 210 more outperform votes than NeuroOne Medical Technologies when rated by MarketBeat users. However, 71.59% of users gave NeuroOne Medical Technologies an outperform vote while only 51.12% of users gave Chembio Diagnostics an outperform vote. CompanyUnderperformOutperformChembio DiagnosticsOutperform Votes27351.12% Underperform Votes26148.88% NeuroOne Medical TechnologiesOutperform Votes6371.59% Underperform Votes2528.41% Do insiders & institutionals have more ownership in CEMI or NMTC? 8.6% of Chembio Diagnostics shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 3.3% of Chembio Diagnostics shares are owned by insiders. Comparatively, 7.5% of NeuroOne Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to CEMI or NMTC? In the previous week, NeuroOne Medical Technologies had 1 more articles in the media than Chembio Diagnostics. MarketBeat recorded 1 mentions for NeuroOne Medical Technologies and 0 mentions for Chembio Diagnostics. NeuroOne Medical Technologies' average media sentiment score of 0.93 beat Chembio Diagnostics' score of 0.00 indicating that NeuroOne Medical Technologies is being referred to more favorably in the news media. Company Overall Sentiment Chembio Diagnostics Neutral NeuroOne Medical Technologies Positive Which has better earnings & valuation, CEMI or NMTC? NeuroOne Medical Technologies has lower revenue, but higher earnings than Chembio Diagnostics. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Chembio Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChembio Diagnostics$48.34M0.35-$23.29M-$1.20-0.38NeuroOne Medical Technologies$1.95M11.23-$11.86M-$0.48-1.48 Is CEMI or NMTC more profitable? Chembio Diagnostics has a net margin of -47.03% compared to NeuroOne Medical Technologies' net margin of -308.51%. Chembio Diagnostics' return on equity of -113.57% beat NeuroOne Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Chembio Diagnostics-47.03% -113.57% -38.22% NeuroOne Medical Technologies -308.51%-276.12%-199.83% Which has more risk & volatility, CEMI or NMTC? Chembio Diagnostics has a beta of 1.85, meaning that its share price is 85% more volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.73, meaning that its share price is 27% less volatile than the S&P 500. SummaryNeuroOne Medical Technologies beats Chembio Diagnostics on 8 of the 15 factors compared between the two stocks. Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. Get NeuroOne Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for NMTC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMTC vs. The Competition Export to ExcelMetricNeuroOne Medical TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.91M$4.45B$5.15B$8.74BDividend YieldN/A41.17%5.18%4.08%P/E Ratio-1.4812.7466.3713.55Price / Sales11.2346.871,276.8487.67Price / CashN/A51.8939.7035.24Price / Book2.735.516.475.93Net Income-$11.86M$13.76M$119.73M$225.73M7 Day Performance-21.86%-6.52%-5.13%-1.34%1 Month Performance-23.55%2.19%-2.71%1.15%1 Year Performance-45.93%50.62%31.08%24.02% NeuroOne Medical Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMTCNeuroOne Medical Technologies0.4235 of 5 stars$0.71-9.0%N/A-46.1%$21.91M$1.95M-1.4816Gap DownHigh Trading VolumeCEMIChembio DiagnosticsN/A$0.46flatN/A+0.0%$16.71M$48.34M-0.38337IDXGInterpace BiosciencesN/A$3.09-5.8%N/A+143.6%$13.60M$40.21M0.00152Gap DownLNSRLENSAR3.1362 of 5 stars$7.49+4.0%N/A+237.1%$87.00M$48.87M-5.13110Short Interest ↓TMDIFTitan MedicalN/A$0.74+4.2%N/A+900.0%$84.39M$17.63M-0.594News CoverageGap DownTELATELA Bio4.0286 of 5 stars$3.06+0.7%N/A-38.5%$75.63M$68.65M-1.81120Short Interest ↓MGRMMonogram Orthopaedics0.9658 of 5 stars$2.02+0.5%N/A-26.0%$70.07M$370,000.00-5.9428Upcoming EarningsNews CoverageHSAQHealth Sciences Acquisitions Co. 2N/A$6.21+2.3%N/A-18.0%$69.63MN/A0.004News CoverageMODDModular Medical3.454 of 5 stars$2.08-2.8%N/A+97.1%$67.73MN/A-3.0639News CoverageNSPRInspireMD2.5246 of 5 stars$2.57+0.8%N/A-12.8%$64.07M$6.20M-3.4350Earnings ReportGap DownNVNOenVVeno Medical1.2372 of 5 stars$3.33-2.3%N/A-26.3%$58.41MN/A-2.5819News Coverage Related Companies and Tools Related Companies CEMI Competitors IDXG Competitors LNSR Competitors TMDIF Competitors TELA Competitors MGRM Competitors HSAQ Competitors MODD Competitors NSPR Competitors NVNO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NMTC) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMTC Stock Alerts